doi: 10.3390/brainsci13111503 64 GleasonPPUrickBYMarshallLZFriedlanderNQiuYLeslieRS
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were initially developed for the management of type 2 diabetes, due to their role in enhancing insulin secretion, decreasing glucagon secretion, and delaying gastric emptying
A 2013 review in Advances in Nutrition notes that several studies have found green tea extract to be beneficial for fat metabolism in both short- and long-term scenarios
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia
These restrictions can create access challenges, particularly for members in areas with limited pharmacy options and they give PBMs opportunities to steer volume toward owned or preferred dispensers
To view or add a comment, sign in The FDA has issued warnings about unapproved GLP-1 drugs circulating online - counterfeit, compounded, or mislabeled as research use only. When access to legitimate GLP-1 clinical trials is limited - by geography, logistics, or site capacity - progress slows